Threebrooks
- Biotech or pharma, therapeutic R&D
Note: Threebrooks is not seeking meetings with CROs during this conference.
Threebrooks is a biotech with expertise and technology in ion channels. We are developing a new drug for Alzheimer's disease using a lysosomal ion channel agonist, TRPML1.We are currently looking for partners to conduct co-development and licensing out.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}